Advertisement

Treating anxiety disorders in children and adolescents with epilepsy: What do we know?

  • Jana E. Jones
    Correspondence
    Tel.: +1 608 262 5481; fax: +1 608 265 0172.
    Affiliations
    University of Wisconsin School of Medicine & Public Health, Department of Neurology, 1685 Highland Ave., Medical Foundation Centennial Building, Room 7229, Madison, WI 53705, USA
    Search for articles by this author

      Abstract

      Children with epilepsy are at significant risk of psychiatric disorders, which can in turn negatively impact social skills development, academic achievement, and quality of life. The most commonly reported psychiatric comorbidities in pediatric epilepsy are ADHD, depression, and anxiety. The prevalence rates of anxiety disorders in pediatric epilepsy range from 5 to 49%, and in the general population, anxiety disorders are the most common psychiatric disorder in childhood. For the purposes of this review, anxiety disorders will be examined in order to 1) examine rates of anxiety disorders in children and adolescents with epilepsy, 2) review treatment options for anxiety disorders in children with epilepsy, and 3) identify future avenues for the development of evidence-based practices for the treatment of anxiety disorders in youth with epilepsy.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Epilepsy & Behavior
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rodenburg R.
        • Wagner J.L.
        • Austin J.K.
        • Kerr M.
        • Dunn D.W.
        Psychosocial issues for children with epilepsy.
        Epilepsy Behav. 2011; 22: 47-54
        • Berg A.T.
        • Caplan R.
        • Hesdorffer D.C.
        Psychiatric and neurodevelopmental disorders in childhood-onset epilepsy.
        Epilepsy Behav. 2011; 20: 550-555
        • Hamiwka L.D.
        • Wirrell E.C.
        Comorbidities in pediatric epilepsy: beyond “just” treating the seizures.
        J Child Neurol. 2009; 24: 734-742
        • Jackson D.C.
        • Dabbs K.
        • Walker N.M.
        • Jones J.E.
        • Hsu D.A.
        • Stafstrom C.E.
        • et al.
        The neuropsychological and academic substrate of new/recent-onset epilepsies.
        J Pediatr. 2013; 162: 1047-1053.e1
        • Rutter M.
        • Graham P.
        • Yule W.
        A neuropsychiatric study in childhood.
        S.I.M.P./William Heineman Medical Books, London1970
        • Davies S.
        • Heyman I.
        • Goodman R.
        A population survey of mental health problems in children with epilepsy.
        Dev Med Child Neurol. 2003; 45: 292-295
        • Ott D.
        • Siddarth P.
        • Gurbani S.
        • Koh S.
        • Tournay A.
        • Shields W.D.
        • et al.
        Behavioral disorders in pediatric epilepsy: unmet psychiatric need.
        Epilepsia. 2003; 44: 591-597
        • Thome-Souza S.
        • Kuczynski E.
        • Assumpcao Jr., F.
        • Rzezak P.
        • Fuentes D.
        • Fiore L.
        • et al.
        Which factors may play a pivotal role on determining the type of psychiatric disorder in children and adolescents with epilepsy?.
        Epilepsy Behav. 2004; 5: 988-994
        • Ekinci O.
        • Titus J.B.
        • Rodopman A.A.
        • Berkem M.
        • Trevathan E.
        Depression and anxiety in children and adolescents with epilepsy: prevalence, risk factors, and treatment.
        Epilepsy Behav. 2009; 14: 8-18
        • Adewuya A.O.
        • Ola B.A.
        Prevalence of and risk factors for anxiety and depressive disorders in Nigerian adolescents with epilepsy.
        Epilepsy Behav. 2005; 6: 342-347
        • Shaffer D.
        • Fisher P.
        • Lucas C.P.
        • Dulcan M.K.
        • Schwab-Stone M.E.
        NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses.
        J Am Acad Child Adolesc Psychiatry. 2000; 39: 28-38
        • Alwash R.H.
        • Hussein M.J.
        • Matloub F.F.
        Symptoms of anxiety and depression among adolescents with seizures in Irbid, Northern Jordan.
        Seizure. 2000; 9: 412-416
        • Caplan R.
        • Sagun J.
        • Siddarth P.
        • Gurbani S.
        • Koh S.
        • Gowrinathan R.
        • et al.
        Social competence in pediatric epilepsy: insights into underlying mechanisms.
        Epilepsy Behav. 2005; 6: 218-228
        • Kaufman J.
        • Birmaher B.
        • Brent D.
        • Rao U.
        • Flynn C.
        • Moreci P.
        • et al.
        Schedule for Affective Disorders and Schizophrenia for School-Age Children—Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.
        J Am Acad Child Adolesc Psychiatry. 1997; 36: 980-988
        • Jones J.E.
        • Watson R.
        • Sheth R.
        • Caplan R.
        • Koehn M.
        • Seidenberg M.
        • et al.
        Psychiatric comorbidity in children with new onset epilepsy.
        Dev Med Child Neurol. 2007; 49: 493-497
        • Costello E.J.
        • Egger H.L.
        • Angold A.
        The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity.
        Child Adolesc Psychiatr Clin N Am. 2005; 14 ([vii]): 631-648
        • Kessler R.C.
        • Lane M.C.
        • Shahly V.
        • Stang P.E.
        Accounting for comorbidity in assessing the burden of epilepsy among US adults: results from the National Comorbidity Survey Replication (NCS-R).
        Mol Psychiatry. 2012; 17: 748-758
        • Merikangas K.R.
        • He J.P.
        • Burstein M.
        • Swanson S.A.
        • Avenevoli S.
        • Cui L.
        • et al.
        Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication—Adolescent Supplement (NCS-A).
        J Am Acad Child Adolesc Psychiatry. 2010; 49: 980-989
        • Kim-Cohen J.
        • Caspi A.
        • Moffitt T.E.
        • Harrington H.
        • Milne B.J.
        • Poulton R.
        Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort.
        Arch Gen Psychiatry. 2003; 60: 709-717
        • Kessler R.C.
        • Avenevoli S.
        • McLaughlin K.A.
        • Green J.G.
        • Lakoma M.D.
        • Petukhova M.
        • et al.
        Lifetime co-morbidity of DSM-IV disorders in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A).
        Psychol Med. 2012; 42: 1997-2010
        • Copeland W.E.
        • Angold A.
        • Shanahan L.
        • Costello E.J.
        Longitudinal patterns of anxiety from childhood to adulthood: the Great Smoky Mountains Study.
        J Am Acad Child Adolesc Psychiatry. 2014; 53: 21-33
        • Hamid H.
        • Ettinger A.B..
        • Mula M.
        Anxiety symptoms in epilepsy: salient issues for future research.
        Epilepsy Behav. 2011; 22: 63-68
        • Mula M.
        Treatment of anxiety disorders in epilepsy: an evidence-based approach.
        Epilepsia. 2013; 54: 13-18
        • Newsom-Davis I.
        • Goldstein L.H.
        • Fitzpatrick D.
        Fear of seizures: an investigation and treatment.
        Seizure. 1998; 7: 101-106
        • Kanner A.M.
        The treatment of depressive disorders in epilepsy: what all neurologists should know.
        Epilepsia. 2013; 54: 3-12
        • Kanner A.M.
        Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy.
        Epilepsy Behav. 2009; 15: 83-87
        • Barry J.J.
        • Ettinger A.B..
        • Friel P.
        • Gilliam F.G.
        • Harden C.L.
        • Hermann B.
        • et al.
        Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders.
        Epilepsy Behav. 2008; 13: S1-S29
        • Kerr M.P.
        • Mensah S.
        • Besag F.
        • de Toffol B.
        • Ettinger A.
        • Kanemoto K.
        • et al.
        International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy.
        Epilepsia. 2011; 52: 2133-2138
        • Connolly S.D.
        • Bernstein G.A.
        • Work Group on Quality I
        Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders.
        J Am Acad Child Adolesc Psychiatry. 2007; 46: 267-283
        • Rapp A.
        • Dodds A.
        • Walkup J.T.
        • Rynn M.
        Treatment of pediatric anxiety disorders.
        Ann N Y Acad Sci. 2013; 1304: 52-61
        • Rynn M.
        • Puliafico A.
        • Heleniak C.
        • Rikhi P.
        • Ghalib K.
        • Vidair H.
        Advances in pharmacotherapy for pediatric anxiety disorders.
        Depress Anxiety. 2011; 28: 76-87
        • Hezel D.M.
        • Beattie K.
        • Stewart S.E.
        Memantine as an augmenting agent for severe pediatric OCD.
        Am J Psychiatry. 2009; 166: 237
        • Mula M.
        • Pini S.
        • Cassano G.B.
        The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence.
        J Clin Psychopharmacol. 2007; 27: 263-272
        • Greist J.H.
        • Liu-Dumaw M.
        • Schweizer E.
        • Feltner D.
        Efficacy of pregabalin in preventing relapse in patients with generalized social anxiety disorder: results of a double-blind, placebo-controlled 26-week study.
        Int Clin Psychopharmacol. 2011; 26: 243-251
        • Stein M.B.
        • Ravindran L.N.
        • Simon N.M.
        • Liebowitz M.R.
        • Khan A.
        • Brawman-Mintzer O.
        • et al.
        Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial.
        J Clin Psychiatry. 2010; 71: 627-631
        • Albano A.M.
        • Kendall P.C.
        Cognitive behavioural therapy for children and adolescents with anxiety disorders: clinical research advances.
        Int Rev Psychiatry. 2002; 14: 129-134
        • Compton S.N.
        • March J.S.
        • Brent D.
        • Albano A.M.T.
        • Weersing R.
        • Curry J.
        Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review.
        J Am Acad Child Adolesc Psychiatry. 2004; 43: 930-959
        • Abramowitz J.S.
        The practice of exposure therapy: relevance of cognitive-behavioral theory and extinction theory.
        Behav Ther. 2013; 44: 548-558
        • Kendall P.C.
        Treating anxiety disorders in children: results of a randomized clinical trial.
        J Consult Clin Psychol. 1994; 62: 100-110
        • Kendall P.C.
        • Southam-Gerow M.A.
        Long-term follow-up of a cognitive-behavioral therapy for anxiety-disordered youth.
        J Consult Clin Psychol. 1996; 64: 724-730
        • Kendall P.C.
        • Flannery-Schroeder E.
        • Panichelli-Mindel S.M.
        • Southam-Gerow M.
        • Henin A.
        • Warman M.
        Therapy for youths with anxiety disorders: a second randomized clinical trial.
        J Consult Clin Psychol. 1997; 65: 366-380
        • Walkup J.T.
        • Albano A.M.
        • Piacentini J.
        • Birmaher B.
        • Compton S.N.
        • Sherrill J.T.
        • et al.
        Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.
        N Engl J Med. 2008; 359: 2753-2766
        • Ginsburg G.S.
        • Kendall P.C.
        • Sakolsky D.
        • Compton S.N.
        • Piacentini J.
        • Albano A.M.
        • et al.
        Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS.
        J Consult Clin Psychol. 2011; 79: 806-813
        • Kendall P.C.
        • Compton S.N.
        • Walkup J.T.
        • Birmaher B.
        • Albano A.M.
        • Sherrill J.
        • et al.
        Clinical characteristics of anxiety disordered youth.
        J Anxiety Disord. 2010; 24: 360-365
        • Hudson J.L.
        • Krain A.L.
        • Kendall P.C.
        Expanding horizons: adapting manual-based treatments for anxious children with comorbid diagnoses.
        Cogn Behav Pract. 2001; 8: 338-346
        • McNally Keehn R.H.
        • Lincoln A.J.
        • Brown M.Z.
        • Chavira D.A.
        The Coping Cat program for children with anxiety and autism spectrum disorder: a pilot randomized controlled trial.
        J Autism Dev Disord. 2013; 43: 57-67
        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders V.
        2013
      1. A. Gonzalez, T.S. Peris, A. Vreeland, C.J. Kiff, P.C. Kendall, S.N. Compton, Parental anxiety as a predictor of medication and CBT response for anxious youth. Child Psychiatry Hum Dev. (in press), [Published online March 2014].

        • Ginsburg G.S.
        • Becker E.M.
        • Keeton C.P.
        • Sakolsky D.
        • Piacentini J.
        • Albano A.M.
        • et al.
        Naturalistic follow-up of youths treated for pediatric anxiety disorders.
        JAMA Psychiatry. 2014; 71: 310-318
        • Drysdale A.T.
        • Hartley C.A.
        • Pattwell S.S.
        • Ruberry E.J.
        • Somerville L.H.
        • Compton S.N.
        • et al.
        Fear and anxiety from principle to practice: implications for when to treat youth with anxiety disorders.
        Biol Psychiatry. 2013; 75: e19-e20
        • Spence S.H.
        • Donovan C.L.
        • March S.
        • Gamble A.
        • Anderson R.
        • Prosser S.
        • et al.
        Online CBT in the treatment of child and adolescent anxiety disorders: issues in the development of BRAVE-ONLINE and two case illustrations.
        Behav Cogn Psychother. 2008; 36: 411-430
        • Spence S.H.
        • Donovan C.L.
        • March S.
        • Gamble A.
        • Anderson R.E.
        • Prosser S.
        • et al.
        A randomized controlled trial of online versus clinic-based CBT for adolescent anxiety.
        J Consult Clin Psychol. 2011; 79: 629-642
        • March S.
        • Spence S.H.
        • Donovan C.L.
        The efficacy of an internet-based cognitive-behavioral therapy intervention for child anxiety disorders.
        J Pediatr Psychol. 2009; 34: 474-487
        • Khanna M.S.
        • Kendall P.C.
        Computer-assisted cognitive behavioral therapy for child anxiety: results of a randomized clinical trial.
        J Consult Clin Psychol. 2010; 78: 737-745
        • Blocher J.B.
        • Fujikawa M.
        • Sung C.
        • Jackson D.C.
        • Jones J.E.
        Computer-assisted cognitive behavioral therapy for children with epilepsy and anxiety: a pilot study.
        Epilepsy Behav. 2013; 27: 70-76
        • Beidas R.S.
        • Lindhiem O.
        • Brodman D.M.
        • Swan A.
        • Carper M.
        • Cummings C.
        • et al.
        A probabilistic and individualized approach for predicting treatment gains: an extension and application to anxiety disordered youth.
        Behav Ther. 2014; 45: 126-136
      2. Epilepsy across the spectrum: promoting health and understanding.
        Institute of Medicine (IOM), Washington, D.C.2012
      3. United States Department of Health and Human Services NIoH. The National Institute of Mental Health Strategic Plan (NIH Publication No. 08-6368). In. Rockville, MD; 2008.

        • Patient-Centered Outcomes Research Institute (PCORI)
        Definition of patient-centered outcomes research.
        (Retrieved April 4, 2014, from)